Comparative analysis on the efficacy of antenatal corticosteroids in preterm newborns in a Kazakhstani Tertiary Care Hospital setting

Table 3 Additional health history of mothers of preterm newborns based on the extent of antenatal steroid prophylaxis, n (%)

Parameters	Additional health history of mothers of preterm newborns based on the extent of antenatal steroid prophylaxis				P value
	Complete, n = 71	Absent, n = 49	Incomplete, n = 32	Total, n = 152
ARVI					0.282
Yes	5 (71.4)	0 (0.0)	2 (28.6)	7 (100)
No	66 (45.5)	49 (33.8)	30 (20.7)	145 (100)
Medical allergy					0.714
Yes	5 (50.0)	4 (40.0)	1 (10.0)	10 (100)
No	66 (46.5)	45 (31.7)	31 (21.8)	142 (100)
Contact dermatitis					0.642
Yes	1 (50.0)	0 (0.0)	1 (50.0)	2 (100)
No	70 (46.7)	49 (32.7)	31 (20.7)	150 (100)
Obesity					0.903
Yes	11 (45.8)	7 (29.2)	6 (25.0)	24 (100)
No	60 (46.9)	42 (32.8)	26 (20.3)	128 (100)
Varicose veins					0.028; α = 0.0167
Yes	15 (71.4)	4 (19.0)	2 (9.5)	21 (100)
No	56 (42.7)	45 (34.4)	30 (22.9)	131 (100)
Myopia					0.759
Yes	3 (42.9)	3 (42.9)	1 (14.3)	7 (100)
No	68 (46.9)	46 (31.7)	31 (21.4)	145 (100)
Retinal angiopathy					0.723
Yes	4 (44.4)	4 (44.4)	1 (11.1)	9 (100)
No	67 (46.9)	45 (31.5)	31 (21.7)	143 (100)